{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:27:34Z","timestamp":1774960054034,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The range of skin disease associated with advanced HIV infection is well described. Effective antiretroviral therapy has modified the spectrum of skin disease associated with HIV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterize the profile of skin conditions occurring in a UK population of people living with HIV (PLHIV) during admission to a tertiary hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review of inpatient admission records was conducted for all patients admitted to a tertiary hospital between January 2018 and December 2022. Data were collected using a standardized data extraction form and analysed with Microsoft Excel using descriptive statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 199 patients [median age 53 years; interquartile range (IQR) 41.5\u201363.0]. The median duration of HIV infection was 12.75 years (IQR 6.10\u201319.58), with a median duration on antiretroviral therapy of 8 years (IQR 0\u201314) and a median CD4 count of 368 (IQR 90\u2013656) on admission. In total, 303 cases of skin disease were identified; the majority were skin infections (n = 164; 54.1%), followed by inflammatory dermatoses (n = 53; 17.5%), skin tumours (n = 39; 12.9%) and drug reactions (n = 13; 4.3%). In 11.2% of cases (n = 34), the diagnosis was unknown. Of the primary skin infections seen, 45.7% (n = 75\/164) were bacterial, 26.8% (n = 44\/164) were viral, 22.0% (n = 36\/164) were fungal and 2.4% (n = 4\/164) were parasitic. The most common condition was cellulitis, which occurred in 45 patients (22.6%). Sixty patients (30.2%) presented with advanced HIV infection (CD4 &amp;lt;200\u2005cells mm\u20133). The most common conditions in this group were oral candidiasis (n = 21; 35%), herpes simplex virus infection (n = 12; 20%), seborrhoeic dermatitis (n = 9; 15%) and Kaposi sarcoma (n = 9; 15%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cutaneous infection was the most common category of skin problem in this population of PLHIV during hospital admission. Bacterial cellulitis was the most common dermatological condition overall, while oral candidiasis was the most common condition in those with advanced HIV infection. Further work is needed to better characterize the profile of skin disease in PLHIV, including in larger prospective cohorts and outpatient settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/skinhd\/vzaf116","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:10:48Z","timestamp":1764249048000},"page":"119-124","source":"Crossref","is-referenced-by-count":0,"title":["Skin conditions in persons living with HIV during hospital admission in the UK"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4999-3116","authenticated-orcid":false,"given":"Jamie","family":"McCluskey","sequence":"first","affiliation":[{"name":"Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex , Brighton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Hickling","sequence":"additional","affiliation":[{"name":"Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex , Brighton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-1717","authenticated-orcid":false,"given":"Collins","family":"Iwuji","sequence":"additional","affiliation":[{"name":"Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex , Brighton ,","place":["UK"]},{"name":"The Lawson Unit, University Hospitals Sussex NHS Foundation Trust, Royal Sussex County Hospital , Brighton ,","place":["UK"]},{"name":"Department of Population Science, Africa Health Research Institute , KwaZulu-Natal ,","place":["South Africa"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3003-0772","authenticated-orcid":false,"given":"David J","family":"Chandler","sequence":"additional","affiliation":[{"name":"Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex , Brighton ,","place":["UK"]},{"name":"Dermatology Department, University Hospitals Sussex NHS Foundation Trust, Brighton General Hospital , Brighton ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026033107433980400_vzaf116-B1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ad.2010.03.021","article-title":"Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection","volume":"101","author":"Blanes","year":"2010","journal-title":"Actas Dermosifiliogr"},{"key":"2026033107433980400_vzaf116-B2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3892\/etm.2020.9529","article-title":"Perspectives on skin disorder diagnosis among people living with HIV in southeastern Romania","volume":"21","author":"Draganescu","year":"2020","journal-title":"Exp Ther Med"},{"key":"2026033107433980400_vzaf116-B3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-4632.2007.03164.x","article-title":"Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts","volume":"46","author":"Goh","year":"2007","journal-title":"Int J Dermatol"},{"key":"2026033107433980400_vzaf116-B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1532\/IJH97.06088","article-title":"Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy","volume":"84","author":"Bernstein","year":"2006","journal-title":"Int J Hematol"},{"key":"2026033107433980400_vzaf116-B5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2230.2009.03620.x","article-title":"Immune reconstitution inflammatory syndrome involving the skin","volume":"35","author":"Osei-Sekyere","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"2026033107433980400_vzaf116-B6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-4362.1995.tb04443.x","article-title":"Ethnic and geographic differences and similarities OE HIV\/AIDS-related mucocutaneous diseases","volume":"34","author":"S\u00f8ndergaard","year":"1995","journal-title":"Int J Dermatol"},{"key":"2026033107433980400_vzaf116-B7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clindermatol.2023.12.005","article-title":"HIV and skin infections","volume":"42","author":"Chandler","year":"2024","journal-title":"Clin Dermatol"},{"key":"2026033107433980400_vzaf116-B8","author":"National Health Service"},{"key":"2026033107433980400_vzaf116-B9","author":"Ewbank"},{"key":"2026033107433980400_vzaf116-B10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/archinte.168.14.1585","article-title":"National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections","volume":"168","author":"Hersh","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026033107433980400_vzaf116-B11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1258\/ijsa.2011.011360","article-title":"Skin and soft tissue infections among HIV-infected persons in the late combination antiretroviral therapy era","volume":"23","author":"Crum-Cianflone","year":"2012","journal-title":"Int J STD AIDS"},{"key":"2026033107433980400_vzaf116-B12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/QAD.0b013e328343c595","article-title":"The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients","volume":"25","author":"Hidron","year":"2011","journal-title":"AIDS"},{"key":"2026033107433980400_vzaf116-B13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tim.2014.01.001","article-title":"A neglected epidemic: fungal infections in HIV\/AIDS","volume":"22","author":"Armstrong-James","year":"2014","journal-title":"Trends Microbiol"},{"key":"2026033107433980400_vzaf116-B14","first-page":"204","article-title":"Profile of candidiasis in HIV infected patients","volume":"4","author":"Anwar","year":"2012","journal-title":"Iran J Microbiol"},{"key":"2026033107433980400_vzaf116-B15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.1988.03410100119036","article-title":"The association between genital ulcer disease and acquisition of HIV infection in homosexual men","volume":"260","author":"Stamm","year":"1988","journal-title":"JAMA"},{"key":"2026033107433980400_vzaf116-B16","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3389\/fmicb.2018.03207","article-title":"\u201cNovel\u201d triggers of herpesvirus reactivation and their potential health relevance","volume":"9","author":"Stoeger","year":"2019","journal-title":"Front Microbiol"},{"key":"2026033107433980400_vzaf116-B17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/422755","article-title":"Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy","volume":"190","author":"Posavad","year":"2004","journal-title":"J Infect Dis"},{"key":"2026033107433980400_vzaf116-B18","doi-asserted-by":"crossref","first-page":"e004210","DOI":"10.1136\/bmjopen-2013-004210","article-title":"Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study","volume":"4","author":"Tan","year":"2014","journal-title":"BMJ Open"},{"key":"2026033107433980400_vzaf116-B19","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/jama.1992.03480130114035","article-title":"Spectrum of disease in persons with human immunodeficiency virus infection in the United States","volume":"267","author":"Farizo","year":"1992","journal-title":"JAMA"},{"key":"2026033107433980400_vzaf116-B20","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1097\/QAD.0b013e32833f9fb8","article-title":"Is Kaposi\u2019s sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?","volume":"24","author":"Crum-Cianflone","year":"2010","journal-title":"AIDS"},{"key":"2026033107433980400_vzaf116-B21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000018087","article-title":"Is there a relation between risk groups or initial CD4 T cell counts and prevalence of seborrheic dermatitis in HIV-infected patients?","volume":"198","author":"Schaub","year":"1999","journal-title":"Dermatology"},{"key":"2026033107433980400_vzaf116-B22"},{"key":"2026033107433980400_vzaf116-B23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2133.1997.tb03793.x","article-title":"The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression","volume":"137","author":"Uthayakumar","year":"1997","journal-title":"Br J Dermatol"},{"key":"2026033107433980400_vzaf116-B24","doi-asserted-by":"crossref","first-page":"2325957417752255","DOI":"10.1177\/2325957417752255","article-title":"Skin diseases in the era of highly active antiretroviral therapy: a retrospective study of 534 patients","volume":"17","author":"Tan","year":"2018","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2026033107433980400_vzaf116-B25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0253-7184.93836","article-title":"Skin diseases in HIV-infected patients: impact of immune status and histological correlation","volume":"33","author":"Halder","year":"2012","journal-title":"Indian J Sex Transm Dis AIDS"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/2\/119\/66844347\/vzaf116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/2\/119\/66844347\/vzaf116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:43:46Z","timestamp":1774957426000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/2\/119\/8471584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,10]]},"published-print":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzaf116","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,10]]}}}